Navigation Links
Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC

CHICAGO, July 28, 2014 /PRNewswire-iReach/ -- June 28th, 2014 – Oncolab, the Boston-based laboratory which has developed the AMAS cancer test, is making its AACC debut (booth #4051) at this year's conference in Chicago.  To date, the test, which is a serum-based in vitro immunoassay, has been run for over 60,000 patients and is emerging as a significant tool in the fight against cancer recurrence.

Photo -

With an estimated 17 million cancer survivors in the US alone, the race is on to develop better technologies for identifying whether a cancer has begun to recur, and if so at what rate.  There is a clear trend towards the use of immunoassays in cancer diagnostics, as immunotherapy for treatment.  The AMAS test fits into these trends by measuring the level of a specific antibody, Anti-Malignin Antibody, which is thought to be produced by the body's immune system in response to nearly all forms of cancer.

Most other cancer immunoassays measure circulating levels of cancer antigens, which become elevated later than the antibody measured in the AMAS test.  As a result, the AMAS Test is an excellent aid to picking up recurrence at an early stage, since levels of anti-malignin antibody are often elevated early in the occurrence and recurrence of cancer.  This is a unique capability – false positive and false negative rates are under 10 percent.  While the AMAS Test does provide guidance as to the likely location of the cancer, new high-resolution imaging techniques such as MRI and CT, as well as more location-specific cancer tests, as well as clinical signs can help the clinician provide patients with the larger context.

Currently, Oncolab provides the test via submission of samples to its CLIA-certified laboratory in Boston, MA.  Serum samples must be shipped via overnight courier (FedEx, UPS or DHL) using a standardized shipping container and tubes provided at no cost by Oncolab, and dry ice obtained at the lab doing the blood draw and separation to serum.  The test is permitted to market by FDA, and reimbursed by Medicare.  Currently, the majority of samples being run are drawn in the US and Canada; overseas labs can also ship samples and are urged to contact Oncolab to get a technical and business relationship started.

The company is also working to develop a version of the test that can be run closer to the point of care; providers of new POC diagnostic platforms are encouraged to meet with the company's representatives at AACC to discuss possible development and deployment options.

Media Contact: Sarah Klein, Oncolab, Inc., 617-536-0850,

News distributed by PR Newswire iReach:

SOURCE Oncolab, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Talyst Exhibits at the National Association of State Veterans Homes Summer Conference
2. Varian Medical Systems Exhibits New Lightweight Wireless Flat-Panel Digital X-ray Image Detector for Imaging Extremities and for Neonatal Procedures
3. Varian Medical Systems Exhibits New Flat-Panel Digital X-ray Image Detectors Designed for High Energy Industrial and Security Applications
4. Kush Bottles Exhibits at Leading Industry Trade Show
5. BioDrain Medical Exhibits at National Registered Nurses Conference
6. Misonix Exhibits at Major Worldwide Spine Conference
7. Frost & Sullivan Applauds Check-Cap for Pioneering a Non-invasive, Prep-Free Wireless Capsule Endoscope
8. Pioneering Medical Device Patent Portfolio for Sale by ICAP Patent Brokerage
9. inVentiv Clinical Trial Recruitment Solutions Partners with Pioneering Firm to Revolutionize Clinical Trial Site Evaluation
10. Genocea Reports Positive Initial Phase 1/2a Results for GEN-003, its Pioneering Therapeutic Vaccine Candidate for the Treatment of Herpes Simplex Virus-2 (HSV-2), at ICAAC 2013
11. inVentiv Health Partner Mytrus Inc. Wins Prestigious Award For Its Pioneering Technology In Electronic Informed Consent
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... of self-monitoring blood glucose devices was valued at $11,171.1 ... with a CAGR of 5.7% during 2015 - 2022. ... population and increasing prevalence of diabetes. In addition, the ... care is also contributing to the growth of the ...
(Date:11/25/2015)... , November 25, 2015 Developmental, commercial, ... role in boosting the profitability of pharmaceutical products, ... commercial, and regulatory/legal strategies all play a ... says GBI Research . --> ... play a key role in boosting the profitability of pharmaceutical products, ...
(Date:11/25/2015)... 25, 2015 --> ... eine Lizenz für das Patent über eine neue Hepatitis-B-Behandlung, ... ENS-Lyon innehaben, an Enyo Pharma vergeben haben. ... Leben gerufenen und von Edelris gemeinsam mit seinen Partnern ... Behandlungsziel für HBV identifiziert, und es wurden neue Inhaltsstoffe ...
Breaking Medicine Technology:
(Date:11/26/2015)... Karnataka (PRWEB) , ... November ... ... innovative online platform for mental health and wellness consultation, has collaborated with ... to holistically address their reader’s queries on topics on mental and emotional ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part of a global ... attracts volunteers together who want to combine talents and resources to help create ... the process. The non-profit launched its first major fundraiser on November 6, 2015 ...
(Date:11/25/2015)... Omaha, Neb. (PRWEB) , ... November 25, 2015 ... ... nurse staffing companies, has been recognized once again for its stellar workplace culture ... Places to Work.” , Medical Solutions’ Cincinnati office was named a ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, senior ... (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, civil societies ... the opening of the 5th African Network for Drugs and Diagnostics Innovation, ANDI, ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article published ... and more widely heralded as a breakthrough for performing hernia repairs. The article explains ... laparoscopic surgery is that it can greatly reduce the pain that a patient might ...
Breaking Medicine News(10 mins):